Literature DB >> 7193484

Studies on the mechanism of the antifibrinolytic action of tranexamic acid.

M Hoylaerts, H R Lijnen, D Collen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7193484

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  52 in total

1.  Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.

Authors:  Keerati Charoencholvanich; Pichet Siriwattanasakul
Journal:  Clin Orthop Relat Res       Date:  2011-04-22       Impact factor: 4.176

2.  Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

Authors:  N Hattori; J L Degen; T H Sisson; H Liu; B B Moore; R G Pandrangi; R H Simon; A F Drew
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

3.  Comparing Cost, Efficacy, and Safety of Intravenous and Topical Tranexamic Acid in Total Hip and Knee Arthroplasty.

Authors:  Joseph F DiBlasi; Ross P Smith; Jeffrey Garavaglia; Jeffrey Quedado; Benjamin M Frye; Matthew J Dietz
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2016 Nov/Dec

Review 4.  Reducing perioperative blood loss with antifibrinolytics and antifibrinolytic-like agents for patients undergoing total hip and total knee arthroplasty.

Authors:  Bhaveen H Kapadia; Barrett B Torre; Nicholas Ullman; Andrew Yang; Matthew A Harb; Preston W Grieco; Jared M Newman; Steven F Harwin; Aditya V Maheshwari
Journal:  J Orthop       Date:  2019-07-02

5.  A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).

Authors:  Y C Ng; D K Peters; S A Cederholm-Williams; M J Walport
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

6.  Topical administration of tranexamic acid in hip arthroplasty.

Authors:  Joon Soon Kang; Kyoung Ho Moon; Bom Soo Kim; Seong Jo Yang
Journal:  Int Orthop       Date:  2016-04-18       Impact factor: 3.075

7.  The voltage-dependent anion channel (VDAC) binds tissue-type plasminogen activator and promotes activation of plasminogen on the cell surface.

Authors:  Mario Gonzalez-Gronow; Rupa Ray; Fang Wang; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

Review 8.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

9.  High dose of tranexamic acid for treatment of severe menorrhagia in patients with von Willebrand disease.

Authors:  Hiroshi Mohri
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

Review 10.  Tranexamic acid and blood loss during and after cesarean section: a meta-analysis.

Authors:  H-Y Wang; S-K Hong; Y Duan; H-M Yin
Journal:  J Perinatol       Date:  2015-07-30       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.